Overview

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness and safety of infliximab (Remicade) in patients with Ulcerative Colitis.
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Infliximab